anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

183,901-183,960 of 319,975

filter-aware
68
The table highlights that all tested Omicron-modified vaccines met the super superiority criterion (GMR lower bound > 1.5).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
69
The table highlights the seroresponse difference and non-inferiority status for participants without prior infection.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
70
The chart compares baseline (Prevax 1MPD) vs post-vaccination GMTs for various BNT162b2 and Bivalent formulations.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
71
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
72
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
73
The chart illustrates the need for faster vaccine development cycles due to the rapid turnover of viral strains.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
74
The slide uses a circular phylogenetic tree to illustrate the dominance of the Omicron clade (GRA) in recent outbreak sequences.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
75
The chart uses a highlighted box to focus on the Omicron period starting December 2021.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
76
Includes a 3D structural model of the RBD with color-coded mutation sites and a corresponding table of amino acid changes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
77
Data shows neutralization titers for OMI and Bivalent vaccines against BA.1 and BA.4/5 variants.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
78
The chart uses a log scale for the y-axis (pVN50 titer).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
79
The chart shows that the Omi BA.4/5 and b2 + Omi BA.4/5 vaccines maintain higher neutralization ratios against Omicron sub-lineages compared to the original BNT162b2 vaccine.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
80
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
81
The diagram uses a hub-and-spoke model centered on 'PREPAREDNESS' feeding into 'Response'.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
82
Slide 82 from a BioNTech presentation.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
83
The slide uses a map-based visual to illustrate a hub-and-spoke network model for vaccine manufacturing.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
84
The slide uses a three-column layout to frame the problem and the proposed solution.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
85
Includes citations at the bottom.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
86
The slide uses a structural biology diagram to explain the modularity of endolysins.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
87
Shows log-scale reduction in CFU/ml for pathogens vs no significant impact on beneficial bacteria.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
88
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
89
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
90
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
91
The slide features a portrait of Özlem Türeci, co-founder and Chief Medical Officer of BioNTech.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
92
The slide maps biological interactions (APC, T cell, Tumor cells) to numbered therapeutic interventions.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
93
The slide uses a Gantt-style visualization for clinical trial phases.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
94
The slide uses a process-flow style to show how different modalities combine to produce specific clinical outcomes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
95
The slide features a stylized, microscopic-style illustration of a molecular structure.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
96
The slide uses a biological process diagram to explain the mechanism of action and a branching logic diagram to explain the product portfolio strategy.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
97
The slide uses a circular process flow for the 5 steps and a feedback loop for the continuous platform evolution.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
98
Includes process flow, flow cytometry data, and scatter plot of TCR frequency.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
99
The slide uses a comparison table to contrast early-line vs late-line settings across three key biological dimensions.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
100
Clinical trial design diagram showing patient flow, randomization, and treatment arms.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
101
The slide uses a process flow diagram to illustrate the current patient journey and outcomes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
102
The slide uses a process flow diagram to illustrate the clinical trial patient journey from screening to randomization and treatment arms.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
103
The slide uses a timeline diagram to show the treatment protocol and lists to summarize clinical context.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
104
Includes a pie chart of responder status and a line chart showing T-cell expansion over time, plus a summary table of median T-cell percentages.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
105
Shows stacked bar chart of neoantigen immunogenicity and a line chart of IFNy spots over time for responders.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
106
Kaplan-Meier plot showing significant difference in RFS between responders and non-responders.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
107
The slide illustrates the modular nature of the FixVac platform, showing how different antigen cassettes are used for specific cancers (Melanoma, HPV16+ HNSCC, Prostate cancer, NSCLC).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
108
The slide uses a combination of metrics and a callout box to frame the clinical problem.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
109
Includes a citation to a Nature article and specific trial results (Lipo-MERIT).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
110
The chart is a 'spider plot' or 'spaghetti plot' tracking individual patient lesion kinetics.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
111
The chart displays individual patient responses, categorized by treatment type and dose, with markers for partial response (PR) and stable disease (SD/irSD).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
112
The slide uses a swimmer plot to visualize disease-free survival and stacked bar charts for T-cell response rates.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
113
The slide uses a process flow diagram to illustrate the trial design.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
114
The table categorizes candidates by platform, indication, and current clinical milestone status.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
115
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
116
Includes binding affinity data and a biological mechanism diagram.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
117
The slide uses a process flow diagram to illustrate the transition from Phase 1 to Phase 2a.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
118
Data cut-off: August 31, 2020. MTD not reached.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
119
Waterfall plot displays individual patient responses categorized by cancer type and prior PD-(L)1 treatment status.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
120
Includes clinical trial data for BNT311; displays best change from baseline and longitudinal change over study weeks.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
01
Slide 1
Canada Goose | Investor Presentation Deck | 24 slidesCanada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations 1 hit
02
Canada Goose | Investor Presentation Deck | 24 slidesCanada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations 1 hit
03
The slide uses a two-column layout to contrast brand identity (left) with operational/financial metrics (right).Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · Problem1 hit
04
This is a cover-style transition slide for the company history section.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · Problem1 hit
05
The slide uses a series of photos paired with descriptive text to illustrate the company's heritage.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a chronological sequence of images and descriptive text to illustrate company growth.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations 1 hit
07
The slide uses a background image of a red jacket with a Canadian flag patch.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations 1 hit